This is a study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring.
Learn More
This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.
Learn More
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.
Learn More
The purpose of this study is to evaluate type 2 diabetes medicine, semaglutide, if it has a positive effect on heart disease.
Learn More
A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis (RLM-MD).
Learn More
Click Here